Eimmunotherapy for immune suppressed patients

Details for Australian Patent Application No. 2007254022 (hide)

Owner IRx Therapeutics, Inc.

Inventors Naylor, Paul; Hadden, John W.

Agent Lord and Company

Pub. Number AU-A-2007254022

PCT Pub. Number WO2007/136910

Priority 11/374,783 14.03.06 US

Filing date 9 March 2007

Wipo publication date 29 November 2007

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/136910 Priority application(s): WO2007/136910

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007254026-Regenerated calcium aluminate product and process of manufacture

2007254018-UV sterilization of user interface fomites